Development and Characterization of a Focally Induced Mouse Model of Glioblastoma Multiforme Originating From Terminally Differentiated Astrocytes

Glioblastoma multiforme (GBM) is a devastating tumor of the central nervous system and is the most frequently occurring primary brain tumor in adults. While much progress has been made in reducing the mortality associated with other forms of cancer, morbidity from GBM remains unchanged. The lack of progress in treatment of GBM highlights the continuing need for accurate preclinical animal models as a means of understanding pathogenesis and providing a resource for testing of potential therapies. To model the development of GBM, we have developed a system using genetically engineered mouse (GEM) models in which silent mutant alleles can be converted to active oncogenes or inactive tumor supressors using the cre-lox recombination system. Through stereotactic injection of replication incompetent lentivirus expressing Cre-recombinase into the cortex of these animals, we have assessed the impact of known effectors of astrocytoma to induce and advance tumors originating from terminally differentiated astrocytes in the context of surrounding normal brain tissue

Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model

Surgical resection is a universal component of glioma therapy. Little is known about the postoperative microenvironment due to limited preclinical models. Thus, we sought to develop a glioma resection and recurrence model in syngeneic immune-competent mice to understand how surgical resection influences tumor biology and the local microenvironment

Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide

Glioma stem cells (GSCs) from human glioblastomas (GBMs) are resistant to radiation and chemotherapy and may drive recurrence. Treatment efficacy may depend on GSCs, expression of DNA repair enzymes such as methylguanine methyltransferase (MGMT), or transcriptome subtype

Modeling Astrocytoma Pathogenesis <em>In Vitro</em> and <em>In Vivo</em> Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Current astrocytoma models are limited in their ability to define the roles of oncogenic mutations in specific brain cell types during disease pathogenesis and their utility for preclinical drug development. In order to design a better model system for these applications, phenotypically wild-type cortical astrocytes and neural stem cells (NSC) from conditional, genetically engineered mice (GEM) that harbor various combinations of floxed oncogenic alleles were harvested and grown in culture. Genetic recombination was induced in vitro using adenoviral Cre-mediated recombination, resulting in expression of mutated oncogenes and deletion of tumor suppressor genes. The phenotypic consequences of these mutations were defined by measuring proliferation, transformation, and drug response in vitro. Orthotopic allograft models, whereby transformed cells are stereotactically injected into the brains of immune-competent, syngeneic littermates, were developed to define the role of oncogenic mutations and cell type on tumorigenesis in vivo. Unlike most established human glioblastoma cell line xenografts, injection of transformed GEM-derived cortical astrocytes into the brains of immune-competent littermates produced astrocytomas, including the most aggressive subtype, glioblastoma, that recapitulated the histopathological hallmarks of human astrocytomas, including diffuse invasion of normal brain parenchyma. Bioluminescence imaging of orthotopic allografts from transformed astrocytes engineered to express luciferase was utilized to monitor in vivo tumor growth over time. Thus, astrocytoma models using astrocytes and NSC harvested from GEM with conditional oncogenic alleles provide an integrated system to study the genetics and cell biology of astrocytoma pathogenesis in vitro and in vivo and may be useful in preclinical drug development for these devastating diseases

Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis

Glioblastoma (GBM) genomes feature recurrent genetic alterations that dysregulate core intracellular signaling pathways, including the G1/S cell cycle checkpoint and the MAPK and PI3K effector arms of receptor tyrosine kinase (RTK) signaling. Elucidation of the phenotypic consequences of activated RTK effectors is required for the design of effective therapeutic and diagnostic strategies

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

Breast cancer brain metastases (BCBM) are a challenging consequence of advanced BC. Nanoparticle agents, including liposomes, have shown enhanced delivery to solid tumors and brain. We compared pharmacokinetics (PK) and efficacy of PEGylated liposomal doxorubicin (PLD) with non-liposomal doxorubicin (NonL-doxo) in an intracranial model of BC

VERITAS and Multiwavelength Observations of the Blazar B3 2247+381 in Response to an IceCube Neutrino Alert

While the sources of the diffuse astrophysical neutrino flux detected by the IceCube Neutrino Observatory are still largely unknown, one of the promising methods to improve our understanding of them is investigating the potential temporal and spatial correlations between neutrino alerts and the electromagnetic radiation from blazars. We report on the multiwavelength target-of-opportunity observations of the blazar B3 2247+381, taken in response to an IceCube multiplet alert for a cluster of muon neutrino events compatible with the source location between 2022 May 20 and 2022 November 10. B3 2247+381 was not detected with VERITAS during this time period. The source was found to be in a low-flux state in the optical, ultraviolet, and gamma-ray bands for the time interval corresponding to the neutrino event, but was detected in the hard X-ray band with NuSTAR during this period. We find the multiwavelength spectral energy distribution is described well using a simple one-zone leptonic synchrotron self-Compton radiation model. Moreover, assuming the neutrinos originate from hadronic processes within the jet, the neutrino flux would be accompanied by a photon flux from the cascade emission, and the integrated photon flux required in such a case would significantly exceed the total multiwavelength fluxes and the VERITAS upper limits presented here. The lack of flaring activity observed with VERITAS, combined with the low multiwavelength flux levels, as well as the significance of the neutrino excess being at a 3σ level (uncorrected for trials), makes B3 2247+381 an unlikely source of the IceCube multiplet. We conclude that the neutrino excess is likely a background fluctuation